Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study
Simple Summary Lenvatinib is an established treatment for radioactive iodine-refractory differentiated thyroid cancer, but long-term real-world data remain limited, particularly in Asian populations. In this multicentre study across seven public hospitals in Hong Kong, we evaluated the effectiveness and safety of lenva...